Concentration of Tc-99m MDP in ovarian carcinoma and its soft tissue metastases. Clin Nucl Med 1991 Aug;16(8):550-2
Date
08/01/1991Pubmed ID
1934805DOI
10.1097/00003072-199108000-00003Scopus ID
2-s2.0-0026210820 (requires institutional sign-in at Scopus site) 19 CitationsAbstract
A patient with ovarian carcinoma was evaluated for skeletal metastasis with a routine whole body bone scan. Although no bone metastases were visualized, there was dramatic accumulation of tracer in the soft tissues of the abdomen. CT revealed calcifying soft tissue metastases on the liver surface, the bowel serosa, and in the pelvis corresponding to the abnormal areas of Tc-99m MDP uptake. Tumor necrosis and ongoing calcification within the metastatic sites are possible explanations for this unusual soft tissue concentration of the bone-seeking radiopharmaceutical. In patients with metastatic ovarian carcinoma, careful review of extraosseous regions on bone scan images may provide valuable diagnostic information.
Author List
Beres RA, Patel N, Krasnow AZ, Isitman AT, Hellman RS, Veluvolu P, Patillo RS, Collier BDAuthor
Robert A. Beres MD Associate Professor in the Radiology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Abdominal NeoplasmsAdult
Bone Neoplasms
Carcinoma, Papillary
Female
Humans
Ovarian Neoplasms
Radionuclide Imaging
Soft Tissue Neoplasms
Technetium Tc 99m Medronate